Pure Global AI
Manufacturer profile

DXGEN CORP.

BrazilSouth Korea4 ANVISA registrations4 unique technical categoriesJan 30, 2023 – May 02, 2023
4
Total products
4
Technical names
Jan 2023
Earliest registration
May 2023
Latest registration
Regulatory footprint
Search DXGEN CORP. across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Top registration holders
Companies holding product registrations for this manufacturer
Top competitors
Companies with the most overlapping products (same technical names)
About this profile

Explore comprehensive manufacturer profile for DXGEN CORP. based in South Korea through Pure Global AI's free Brazil medical device database. This manufacturer has 4 products registered with ANVISA across 4 unique technical categories. Their regulatory history spans from Jan 30, 2023 to May 02, 2023.

This page provides detailed insights including 4 recent product registrations including Instrument for analysis of general biochemistry, hormones, drugs or proteins, 4 most popular products with Instrument for analysis of general biochemistry, hormones, drugs or proteins having 1 registrations, 1 registration holders including CAPRICORN TECHNOLOGIES DO BRASIL LTDA, and 5 key competitors with ROCHE DIAGNOSTICS GMBH sharing 4 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.